Successful treatment of antiepileptic drug hypersensitivity syndrome with intravenous immune globulin
被引:39
作者:
Scheuerman, O
论文数: 0引用数: 0
h-index: 0
机构:Schneider Childrens Med Ctr Israel, Dept Pediat A, IL-49181 Petah Tiqwa, Israel
Scheuerman, O
Nofech-Moses, Y
论文数: 0引用数: 0
h-index: 0
机构:Schneider Childrens Med Ctr Israel, Dept Pediat A, IL-49181 Petah Tiqwa, Israel
Nofech-Moses, Y
Rachmel, A
论文数: 0引用数: 0
h-index: 0
机构:Schneider Childrens Med Ctr Israel, Dept Pediat A, IL-49181 Petah Tiqwa, Israel
Rachmel, A
Ashkenazi, S
论文数: 0引用数: 0
h-index: 0
机构:
Schneider Childrens Med Ctr Israel, Dept Pediat A, IL-49181 Petah Tiqwa, IsraelSchneider Childrens Med Ctr Israel, Dept Pediat A, IL-49181 Petah Tiqwa, Israel
Ashkenazi, S
[1
]
机构:
[1] Schneider Childrens Med Ctr Israel, Dept Pediat A, IL-49181 Petah Tiqwa, Israel
[2] Schneider Childrens Med Ctr Israel, Clin Pharmacol Unit, IL-49181 Petah Tiqwa, Israel
[3] Schneider Childrens Med Ctr Israel, Infect Dis Unit, IL-49181 Petah Tiqwa, Israel
[4] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel
Intravenous immune globulin (IVIG) has proved beneficial for severe immunologically related cutaneous adverse reactions. We report a child with severe antiepileptic drug hypersensitivity syndrome who was successfully treated with IVIG. IVIG should be considered in the pharmacologic armamentarium of severe antiepileptic drug hypersensitivity syndrome.